Joining Dr. Matt Birnholz at the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois, is Dr. Jonathan Strauss to discuss the talks he’s given at this year’s conference on the evolution of radiation oncology as a field, challenging breast cancer cases, and emerging factors that support the emission of radiotherapy in invasive cancers.

Tune in to hear Dr. William Gradishar break down his presentations as well as other highlights attendees can look forward to at the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois.

Learn more about the mission of the Lurie Cancer Center’s Lynn Sage Breast Cancer Symposium and the topics featured at the 2019 conference from Dr. William Gradishar, who’s served as the Chair of the Lynn Sage Breast Cancer Symposium since its inception in 1998.

Cancer Discovery is a publication journal for the American Association for Cancer Research, and at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, Dr. Matt Birnholz sat down with its editor, Dr. I-Mei Siu, to learn more about the journal’s mission and the key updates presented at the conference.

Get an in-depth look at the reality of the patient experience with endocrine treatment after breast cancer surgery with Dr. Matt Birnholz and Dr. Susanne Ahlstedt-Karlsson at the 2019 European Society for Medical Oncology(ESMO) Congress in Barcelona, Spain.

Known for his early drug development research for breast cancer, Dr. Giuseppe Curigliano joins Dr. Matt Birnholz at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain to talk about the latest research in treatment developments for triple-negative breast cancer as well as insights on what’s coming ahead on the future horizons for this cancer subtype.

The European Society of Medical Oncology (ESMO) Congress is held each year to bring together clinicians and researchers from all over the world, and at this year’s conference, new and emerging breast cancer treatments took center stage. Tune in as Dr. Matt Birnholz recaps those advances on the ESMO Congress floor in Barcelona, Spain.

Joining Dr. Matt Birnholz at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain to talk about his recent study titled, Agreement Between Patients and Oncologists on the Severity of the Patient’s Symptoms and Functions During a One-Year Follow-Up After Breast Cancer Treatment, is Dr. Randi Reidunsdatter.

At the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, Dr. Matt Birnholz got a chance to talk with Dr. Hans Petter Eikesdal about the head-turning study on PARP inhibitors he presented at the conference.

The curriculum will include highlights from the National Lipid Association symposium presented in a multi-part, structured activity that is engaging and interactive.